Skyrizi 150 MG/ML penml

Ended Awarded Last action

Contract number
SPE2DR26FA4M5
Awardee
Awarding agency
Obligated
$58,019

Award facts

Contract value 100% obligated
$58,019.24 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $58,019.24 delivery order to Amerisourcebergen Drug Corp on February 4, 2026, for SKYRIZI 150 mg/ml (risankizumab injection), with an ultimate completion date of February 5, 2026.

The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) held by Cencora, Inc., Amerisourcebergen's parent organization. This IDC is valued at up to $999,999,999 through December 2031 and covers pharmaceutical products and medical supplies supporting military healthcare programs globally. The order carries firm fixed pricing and is not set-aside. Place of performance is Conshohocken, Pennsylvania.

Quick answers

Who was awarded contract SPE2DR26FA4M5?

SPE2DR26FA4M5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.

How much is contract SPE2DR26FA4M5 worth?

The government has obligated $58,019 on SPE2DR26FA4M5.

Is contract SPE2DR26FA4M5 an order under another contract?

Yes. SPE2DR26FA4M5 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.

Was contract SPE2DR26FA4M5 competed?

The extent of competition for SPE2DR26FA4M5 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award